Clinical Trials Directory

Trials / Completed

CompletedNCT06612801

REThinkGame4training: Training Emotion Regulation Abilities Using an Online Therapeutic Game

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
237 (actual)
Sponsor
Babes-Bolyai University · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Accepted

Summary

To test the efficacy of the REThink therapeutic game in training emotion regulation abilities of children and adolescents.

Detailed description

The primary aim of this study is to evaluate the effectiveness of the REThink therapeutic game in training emotion regulation abilities in children aged 8 to 12 years. The participants will be recruitedfrom various schools and counties, ensuring a diverse sample. Those in the experimental group will engage with the REThink game over a four-week period. To assess the impact of the intervention, standardized pre-test and post-test measures will be administered, allowing for a comparison of mental health outcomes before and after the use of the therapeutic game. The study seeks to determine whether this digital tool can serve as an effective training for improving emotion regulation abilities in this age group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALThe REThink GameREThink is an online therapeutic game designed to improve the emotional well-being of young people, based on the principles of Rational Emotive Behavior Therapy (REBT). The game features a character named RETMAN, who leads players through seven levels, each dedicated to teaching a particular emotional regulation skill. Each level consists of three sub-levels that gradually become more challenging. REThink can be utilized as a standalone intervention, as a complement to self-help psychotherapeutic methods, or for focused skills training in emotional regulation. Each level trains a specific emoion-regulation skills such as emotion recognition, relaxation, cognitive change, problem solving, compassion and self-compassion.

Timeline

Start date
2021-04-01
Primary completion
2022-04-01
Completion
2022-07-31
First posted
2024-09-25
Last updated
2024-09-25

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT06612801. Inclusion in this directory is not an endorsement.